Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9712485rdf:typepubmed:Citationlld:pubmed
pubmed-article:9712485lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:9712485lifeskim:mentionsumls-concept:C0856825lld:lifeskim
pubmed-article:9712485lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:9712485pubmed:dateCreated1998-11-24lld:pubmed
pubmed-article:9712485pubmed:abstractTextAcute graft-versus-host disease (GVHD), the major complication of allogeneic bone marrow transplantation (BMT), significantly limits the application of this important therapy. Advances in basic immunobiology, and particularly in the dissection of the complex networks of cytokines that affect the function of immune cells, have increased our understanding of the effector mechanisms of acute GVHD. Data from both experimental and clinical studies suggest that inflammatory cytokines are critical components of acute GVHD that can be modulated by a number of proteins, including anti-inflammatory cytokines and cytokine antagonists.lld:pubmed
pubmed-article:9712485pubmed:languageenglld:pubmed
pubmed-article:9712485pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9712485pubmed:citationSubsetIMlld:pubmed
pubmed-article:9712485pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9712485pubmed:statusMEDLINElld:pubmed
pubmed-article:9712485pubmed:monthJunlld:pubmed
pubmed-article:9712485pubmed:issn0268-3369lld:pubmed
pubmed-article:9712485pubmed:authorpubmed-author:FerraraJ LJLlld:pubmed
pubmed-article:9712485pubmed:issnTypePrintlld:pubmed
pubmed-article:9712485pubmed:volume21 Suppl 3lld:pubmed
pubmed-article:9712485pubmed:ownerNLMlld:pubmed
pubmed-article:9712485pubmed:authorsCompleteYlld:pubmed
pubmed-article:9712485pubmed:paginationS13-5lld:pubmed
pubmed-article:9712485pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:meshHeadingpubmed-meshheading:9712485-...lld:pubmed
pubmed-article:9712485pubmed:year1998lld:pubmed
pubmed-article:9712485pubmed:articleTitleThe cytokine modulation of acute graft-versus-host disease.lld:pubmed
pubmed-article:9712485pubmed:affiliationDivision of Pediatric Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115, USA.lld:pubmed
pubmed-article:9712485pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9712485pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9712485lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9712485lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9712485lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9712485lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9712485lld:pubmed